About Us

Medone Research brings together the expertise, highest quality services and understanding that come from more than 15 years of managing global clinical trials within the CEE region together with the first-hand local knowledge, cost-effectiveness and flexibility.

Our extensive medical expertise, clinical research and regulatory experience are used to deliver our clients with superior quality services in each and every phase of the clinical trial.

We are addressing the needs of pharmaceutical, biotechnology or medical devices companies as well as academic, having the expertise, experience and flexibility to deliver superior results, according to our client’s needs. At Medone Research, we aim to build long-term relationships that ensure results. Communication throughout all phases of the clinical trial is essential to building successful partnerships – with Sponsors, research sites, and patients.
We are committed to offer real solutions. Our aim is to provide the best possible CRO services to small and medium-size pharmaceutical, biotech and medical devices companies.

Medone Research shares a common goal with our Sponsors – advancing new therapeutic solutions from early development phases towards regulatory approval. Our aim is to perform this process in the most accurate, flexible, efficient and cost-effective manner. We are a dedicated partner for our Sponsors and every project team is tailored to serve as an effective extension of the Sponsor’s team.

Partnering with the right investigators to meet recruitment challenges across all research sites is critical for having successful clinical trials. Medone Research knows what’s most important to investigators –an open, effective and proactive communication, good protocol design, good planning and organization of project activities. Our CRAs have built long standing and positive partnerships with each of our research sites, in our key therapeutic areas.

Medone Research through an established network partnership is able to run successfully clinical trials phase II-III and late – phase research across the CEE region, due to its expertise, careful planning and highly qualified staff. Our team is committed to the “win-win” strategy by providing outstanding quality, on-time delivery and cost-efficiency.

Our extensive network of KOL and capable investigators, with vast experience in clinical and academic research, enable us to undertake projects in several countries within CEE region.